Asset Details
Do you wish to reserve the book?
Baicalin Represses Type Three Secretion System of Pseudomonas aeruginosa through PQS System
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Baicalin Represses Type Three Secretion System of Pseudomonas aeruginosa through PQS System
Do you wish to request the book?
Baicalin Represses Type Three Secretion System of Pseudomonas aeruginosa through PQS System
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Baicalin Represses Type Three Secretion System of Pseudomonas aeruginosa through PQS System
2021
Overview
Therapeutics that target the virulence of pathogens rather than their viability offer a promising alternative for treating infectious diseases and circumventing antibiotic resistance. In this study, we searched for anti-virulence compounds against Pseudomonas aeruginosa from Chinese herbs and investigated baicalin from Scutellariae radix as such an active anti-virulence compound. The effect of baicalin on a range of important virulence factors in P. aeruginosa was assessed using luxCDABE-based reporters and by phenotypical assays. The molecular mechanism of the virulence inhibition by baicalin was investigated using genetic approaches. The impact of baicalin on P. aeruginosa pathogenicity was evaluated by both in vitro assays and in vivo animal models. The results show that baicalin diminished a plenty of important virulence factors in P. aeruginosa, including the Type III secretion system (T3SS). Baicalin treatment reduced the cellular toxicity of P. aeruginosa on the mammalian cells and attenuated in vivo pathogenicity in a Drosophila melanogaster infection model. In a rat pulmonary infection model, baicalin significantly reduced the severity of lung pathology and accelerated lung bacterial clearance. The PqsR of the Pseudomonas quinolone signal (PQS) system was found to be required for baicalin’s impact on T3SS. These findings indicate that baicalin is a promising therapeutic candidate for treating P. aeruginosa infections.
Publisher
MDPI AG,MDPI
Subject
/ Animals
/ Anti-Bacterial Agents - pharmacology
/ Bacterial Proteins - genetics
/ baicalin
/ China
/ Drosophila melanogaster - metabolism
/ Drosophila Proteins - drug effects
/ Drosophila Proteins - metabolism
/ Female
/ Genes
/ Herbs
/ Motility
/ Pseudomonas aeruginosa - drug effects
/ Pseudomonas aeruginosa - metabolism
/ Pseudomonas Infections - drug therapy
/ Quorum Sensing - drug effects
/ Rats
/ Transcription Factors - therapeutic use
/ Type III Secretion Systems - drug effects
